New study highlights the need for advanced pneumococcal vaccines in the wake of pre-COVID data Post author: Post published:December 14, 2023 Post category:uncategorized The risk factors associated with CAP caused by serotypes in the different pneumococcal vaccines. You Might Also Like VALANX Biotech establishes Scientific Advisory Board to advance ADC therapeutics April 15, 2026 Industrial and farm chemicals quietly alter the balance of gut microbes December 8, 2025 Climate change fuels worry and hopelessness among Canadian teenagers October 15, 2025